<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK475803" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK475803/" /><meta name="ncbi_pagename" content="PRRT2-Associated Paroxysmal Movement Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>PRRT2-Associated Paroxysmal Movement Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="PRRT2-Associated Paroxysmal Movement Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/01/11" /><meta name="citation_author" content="Darius Ebrahimi-Fakhari" /><meta name="citation_author" content="Christelle Moufawad El Achkar" /><meta name="citation_author" content="Christine Klein" /><meta name="citation_pmid" content="29334453" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK475803/" /><meta name="citation_keywords" content="PRRT2-PxMD" /><meta name="citation_keywords" content="PRRT2-PxMD" /><meta name="citation_keywords" content="Benign Familial Infantile Epilepsy (BFIE)" /><meta name="citation_keywords" content="Paroxysmal Kinesigenic Dyskinesia (PKD)" /><meta name="citation_keywords" content="Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions (PKD/IC)" /><meta name="citation_keywords" content="Hemiplegic Migraine (HM)" /><meta name="citation_keywords" content="Proline-rich transmembrane protein 2" /><meta name="citation_keywords" content="PRRT2" /><meta name="citation_keywords" content="PRRT2-Associated Paroxysmal Movement Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="PRRT2-Associated Paroxysmal Movement Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Darius Ebrahimi-Fakhari" /><meta name="DC.Contributor" content="Christelle Moufawad El Achkar" /><meta name="DC.Contributor" content="Christine Klein" /><meta name="DC.Date" content="2018/01/11" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK475803/" /><meta name="description" content="PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC." /><meta name="og:title" content="PRRT2-Associated Paroxysmal Movement Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK475803/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/prrt2-parox/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK475803/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8976B4E040E5A10000000003690188.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK475803_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK475803_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/prop1/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/prss1-hp/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK475803_"><span class="title" itemprop="name"><i>PRRT2</i>-Associated Paroxysmal Movement Disorders</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: <i>PRRT2-</i>PxMD</div><p class="contrib-group"><span itemprop="author">Darius Ebrahimi-Fakhari</span>, MD, PhD, <span itemprop="author">Christelle Moufawad El Achkar</span>, MD, and <span itemprop="author">Christine Klein</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK475803_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK475803_ai__"><div class="contrib half_rhythm"><span itemprop="author">Darius Ebrahimi-Fakhari</span>, MD, PhD<div class="affiliation small">Boston Children's Hospital<br />Harvard Medical School<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.snerdlihc@irahkaf-imiharbe.suirad" class="oemail">ude.dravrah.snerdlihc@irahkaf-imiharbe.suirad</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Christelle Moufawad El Achkar</span>, MD<div class="affiliation small">Boston Children's Hospital<br />Harvard Medical School<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.snerdlihc@rakhca.elletsirhc" class="oemail">ude.dravrah.snerdlihc@rakhca.elletsirhc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Christine Klein</span>, MD<div class="affiliation small">Institute of Neurogenetics<br />University of L&#x000fc;beck<br />L&#x000fc;beck, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.kcebeul-inu.oruen@nielk.enitsirhc" class="oemail">ed.kcebeul-inu.oruen@nielk.enitsirhc</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 11, 2018</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="prrt2-parox.Summary" itemprop="description"><h2 id="_prrt2-parox_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>PRRT2</i>-associated paroxysmal movement disorders (<i>PRRT2-</i>PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, <i>PRRT2</i> pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of <i>PRRT2</i>-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of <i>PRRT2</i>-associated PKD is associated with BFIE and is referred to as PKD/IC.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>PRRT2</i>-PxMD is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who has one of the following three findings on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>: a <i>PRRT2</i> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (~99% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals); the 16p11.2 <a class="def" href="/books/n/gene/glossary/def-item/recurrent-deletion/">recurrent deletion</a> that includes <i>PRRT2</i> (&#x0003c;1% of affected individuals); or <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>PRRT2</i> pathogenic variants (&#x0003c;1% of affected individuals, typically those with a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>).</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> PKD attack frequency is reduced or prevented by treatment with low doses of antiepileptic drugs (AEDs). Avoiding stress, sleep deprivation, anxiety, and other triggers that can precipitate PKD episodes can help prevent attacks and can lower attack frequency. For BFIE, seizure frequency is decreased by therapeutic doses of AEDs; seizures lasting longer than five minutes or seizure clusters may respond to use of benzodiazepines. Seizures tend to spontaneously remit by age two years.</p><p><i>Surveillance:</i> Individuals with PKD or PKD/IC can be monitored clinically every one to two years, particularly with respect to evaluating medication needs and dosing. Individuals with BFIE are monitored clinically for seizures; AEDs are adjusted accordingly.</p><p><i>Agents/circumstances to avoid:</i> PKD: Avoid triggers known to precipitate attacks.</p><p><i>Pregnancy management:</i> Prenatal exposure to AEDs may increase the risk for adverse fetal outcome (depending on the drug used, the dose, and the stage of pregnancy at which medication is taken). Discussion of the risks and benefits of using a given AED during pregnancy should ideally take place prior to conception.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>PRRT2</i>-PxMD caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>PRRT2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or, rarely, the 16p11.2 <a class="def" href="/books/n/gene/glossary/def-item/recurrent-deletion/">recurrent deletion</a> (that includes <i>PRRT2</i>) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Rarely <i>PRRT2</i>-PxMD (typically associated with a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. For autosomal dominant <i>PRRT2</i>-PxMD: approximately 90% of pathogenic variants are inherited and 10% are <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>. Each child of an individual with <i>PRRT2</i>-PxMD has a 50% chance of inheriting the <i>PRRT2</i> pathogenic variant. Once the <i>PRRT2</i> pathogenic variant(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible; however, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> lead to phenotypic variability within families.</p></div></div><div id="prrt2-parox.GeneReview_Scope"><h2 id="_prrt2-parox_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="prrt2-parox.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK475803/table/prrt2-parox.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prrt2-parox.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_prrt2-parox.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRRT2</i>-Associated Paroxysmal Movement Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_prrt2-parox.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Paroxysmal kinesigenic dyskinesia (PKD)</div></li><li class="half_rhythm"><div>Benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile epilepsy (BFIE)</div></li><li class="half_rhythm"><div>Paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC)</div></li><li class="half_rhythm"><div>Hemiplegic migraine (HM)</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#prrt2-parox.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="prrt2-parox.TF.d.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#prrt2-parox.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="prrt2-parox.Diagnosis"><h2 id="_prrt2-parox_Diagnosis_">Diagnosis</h2><div id="prrt2-parox.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>PRRT2</i>-associated paroxysmal movement disorders (<i>PRRT2-</i>PxMD) <b>should be considered</b> in individuals with any one of the following four phenotypes and/or in individuals with a paroxysmal movement disorder and a positive family history of any of the four phenotypes:</p><div id="prrt2-parox.Paroxysmal_Kinesigenic_Dyski"><h4>Paroxysmal Kinesigenic Dyskinesia (PKD)</h4><p><b>PKD</b> characterized by the following clinical and supportive findings (adapted from <a class="bk_pop" href="#prrt2-parox.REF.bruno.2004.2280">Bruno et al [2004]</a>):</p><ul><li class="half_rhythm"><div><b>Clinical findings.</b> Sudden attacks of unilateral or bilateral involuntary movements (dyskinesias that can include a combination of dystonia, chorea, ballism, or athetosis) and the following:</div><ul><li class="half_rhythm"><div>Onset between ages one and 20 years</div></li><li class="half_rhythm"><div>A kinesigenic trigger (e.g., sudden voluntary movements or being startled)</div></li><li class="half_rhythm"><div>An aura preceding attacks (10% of individuals)</div></li><li class="half_rhythm"><div>Short duration (typically &#x0003c;1 minute)</div></li><li class="half_rhythm"><div>High frequency (sometimes as many as 100 times/day)</div></li><li class="half_rhythm"><div>No loss of consciousness or pain during attacks</div></li><li class="half_rhythm"><div>Prevention or control with phenytoin or carbamazepine</div></li></ul></li><li class="half_rhythm"><div><b>Supportive findings</b></div><ul><li class="half_rhythm"><div>Normal neurologic examination between attacks</div></li><li class="half_rhythm"><div>Normal brain MRI</div></li><li class="half_rhythm"><div>No EEG changes during the attacks</div></li></ul></li></ul></div><div id="prrt2-parox.Benign_Familial_Infantile_Ep"><h4>Benign Familial Infantile Epilepsy (BFIE)</h4><p><b>BFIE</b> characterized by the following clinical and supportive findings [<a class="bk_pop" href="#prrt2-parox.REF.watanabe.1987.208">Watanabe et al 1987</a>, <a class="bk_pop" href="#prrt2-parox.REF.vigevano.2005.172">Vigevano 2005</a>, <a class="bk_pop" href="#prrt2-parox.REF.specchio.2006.s156">Specchio &#x00026; Vigevano 2006</a>]:</p><ul><li class="half_rhythm"><div><b>Clinical findings.</b> Complex partial seizures or localization-related epilepsy (focal, typically with altered awareness, and a unilateral motor component that can involve either side of the body in the same individual) with the following:</div><ul><li class="half_rhythm"><div>Onset in the first year of life (most commonly 4-12 months)</div></li><li class="half_rhythm"><div>Either spontaneous or occuring in the context of fever [<a class="bk_pop" href="#prrt2-parox.REF.scheffer.2012.2104">Scheffer et al 2012</a>]</div></li><li class="half_rhythm"><div>Can occur in clusters of multiple seizures per day: up to eight to ten seizures per day occurring every two to three hours on average</div></li><li class="half_rhythm"><div>Excellent response to antiepileptic drugs (AEDs)</div></li><li class="half_rhythm"><div>Resolution by age two years</div></li></ul></li><li class="half_rhythm"><div><b>Supportive findings</b></div><ul><li class="half_rhythm"><div>Otherwise normal development and normal developmental outcome</div></li><li class="half_rhythm"><div>Normal neurologic examination</div></li><li class="half_rhythm"><div>Normal brain imaging and EEG background signal</div></li></ul></li></ul></div><div id="prrt2-parox.Paroxysmal_Kinesigenic_Dyski_1"><h4>Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions (PKD/IC)</h4><p><b>PKD/IC</b> characterized by both of the following phenotypes:</p><ul><li class="half_rhythm"><div>Paroxysmal movement disorder that meets criteria for PKD</div></li><li class="half_rhythm"><div>Seizures that meet criteria for BFIE</div></li></ul></div><div id="prrt2-parox.Hemiplegic_Migraine_HM"><h4>Hemiplegic Migraine (HM)</h4><p><b>HM</b> (The International Classification of Headache Disorders ICHD-3 beta [<a class="bk_pop" href="#prrt2-parox.REF10">Headache Classification Committee 2013</a>]) characterized by:</p><ul><li class="half_rhythm"><div>Migraine with aura</div></li><li class="half_rhythm"><div>Aura that includes some degree of hemiparesis and may be prolonged</div></li></ul><p>Note: Heterozygous <i>PRRT2</i> pathogenic variants have been described in persons with HM who represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) [<a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>].</p></div></div><div id="prrt2-parox.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>PRRT2-</i>PxMD <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who meets clinical criteria and has one of the following on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK475803/table/prrt2-parox.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figprrt2paroxTmoleculargenetictesting" rid-ob="figobprrt2paroxTmoleculargenetictesting">Table 1</a>):</p><ul><li class="half_rhythm"><div>A <i>PRRT2</i> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (~99% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) [<a class="bk_pop" href="#prrt2-parox.REF.chen.2011.1252">Chen et al 2011</a>, <a class="bk_pop" href="#prrt2-parox.REF.wang.2011.3493">Wang et al 2011</a>, <a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>]</div></li><li class="half_rhythm"><div>The <a href="/books/n/gene/del16p11_2/">16p11.2 recurrent deletion</a> that includes <i>PRRT2</i> (&#x0003c;1% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) [<a class="bk_pop" href="#prrt2-parox.REF.dale.2012.618">Dale et al 2012</a>, <a class="bk_pop" href="#prrt2-parox.REF.silveiramoriyama.2013.327">Silveira-Moriyama et al 2013</a>, <a class="bk_pop" href="#prrt2-parox.REF.weber.2013.251">Weber et al 2013</a>, <a class="bk_pop" href="#prrt2-parox.REF.termsarasab.2014.274">Termsarasab et al 2014</a>, <a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>]</div></li><li class="half_rhythm"><div>Biallelic <i>PRRT2</i> pathogenic variants (&#x0003c;1% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) [<a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>] observed in rare instances of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance in individuals with a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#prrt2-parox.REF.labate.2012.e196">Labate et al 2012</a>, <a class="bk_pop" href="#prrt2-parox.REF.delcourt.2015.782">Delcourt et al 2015</a>]</div></li></ul><p>Molecular genetic testing approaches can include <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (typically targeted sequencing of <i>PRRT2</i> or a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis [CMA] and genomic sequencing).</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Individuals with the distinctive findings described in <a href="#prrt2-parox.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#prrt2-parox.Option_1">Option 1</a>), whereas those with a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> indistinguishable from a wide range of other paroxysmal disorders are likely to be diagnosed using either a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or genomic testing (i.e., <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>) (see <a href="#prrt2-parox.Option_2">Option 2</a>).</p><div id="prrt2-parox.Option_1"><h4>Option 1</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and family history suggest the diagnosis of <i>PRRT2-</i>PxMD, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>PRRT2</i> is performed first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> should be performed next.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> for PKD, BFIE PKD/IC, or HM may also be considered.</div><div class="half_rhythm">Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Given the rarity of <i>PRRT2-</i>associated paroxysmal disorders, clinicians should ensure that <i>PRRT2</i> is included in gene panels for the phenotypes observed in this wide spectrum of neurologic findings. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK475803/table/prrt2-parox.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figprrt2paroxTmoleculargenetictesting" rid-ob="figobprrt2paroxTmoleculargenetictesting">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="prrt2-parox.Option_2"><h4>Option 2</h4><p>When the diagnosis of <i>PRRT2-</i>PxMD has not been considered, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> is likely to be the diagnostic modality selected. Genomic sequencing (when clinically available) includes <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="prrt2-parox.T.molecular_genetic_testing" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>PRRT2</i>-Associated Paroxysmal Movement Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK475803/table/prrt2-parox.T.molecular_genetic_testing/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prrt2-parox.T.molecular_genetic_testing_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_prrt2-parox.T.molecular_genetic_testing_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_prrt2-parox.T.molecular_genetic_testing_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_prrt2-parox.T.molecular_genetic_testing_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_prrt2-parox.T.molecular_genetic_testing_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRRT2</i></td><td headers="hd_h_prrt2-parox.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_prrt2-parox.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">99%</td></tr><tr><td headers="hd_h_prrt2-parox.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_prrt2-parox.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td></tr><tr><td headers="hd_h_prrt2-parox.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">CMA&#x000a0;<sup>6</sup></td><td headers="hd_h_prrt2-parox.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="prrt2-parox.TF.1.1"><p class="no_margin">See <a href="/books/NBK475803/#prrt2-parox.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="prrt2-parox.TF.1.2"><p class="no_margin">See <a href="#prrt2-parox.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="prrt2-parox.TF.1.3"><p class="no_margin"><a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al [2015]</a></p></div></dd><dt>4. </dt><dd><div id="prrt2-parox.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="prrt2-parox.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications. These methods will detect single-exon up to whole-gene deletions; however, breakpoints of large deletions and/or deletion of adjacent genes, such as the 16p11.2 <a class="def" href="/books/n/gene/glossary/def-item/recurrent-deletion/">recurrent deletion</a>, may not be defined by these methods.</p></div></dd><dt>6. </dt><dd><div id="prrt2-parox.TF.1.6"><p class="no_margin">Chromosomal microarray analysis (CMA) using oligonucleotide or SNP arrays detects copy number variants and defines breakpoints of large deletions, including the 16p11.2 <a class="def" href="/books/n/gene/glossary/def-item/recurrent-deletion/">recurrent deletion</a>.</p></div></dd></dl></div></div></div></div></div></div><div id="prrt2-parox.Clinical_Characteristics"><h2 id="_prrt2-parox_Clinical_Characteristics_">Clinical Characteristics</h2><div id="prrt2-parox.Clinical_Description"><h3>Clinical Description</h3><p>The core phenotypes of <i>PRRT2</i>-associated paroxysmal movement disorders (<i>PRRT2-</i>PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, <i>PRRT2</i> pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, including a small number of individuals who meet clinical criteria for <a href="/books/n/gene/pnknd/">paroxysmal nonkinesigenic dyskinesia</a> (PNKD) [<a class="bk_pop" href="#prrt2-parox.REF.liu.2012.79">Liu et al 2012</a>, <a class="bk_pop" href="#prrt2-parox.REF.becker.2013.1234">Becker et al 2013</a>, <a class="bk_pop" href="#prrt2-parox.REF.liu.2013.234">Liu et al 2013</a>, <a class="bk_pop" href="#prrt2-parox.REF.wang.2013.664">Wang et al 2013</a>, <a class="bk_pop" href="#prrt2-parox.REF.delcourt.2015.782">Delcourt et al 2015</a>], paroxysmal exertion-induced dyskinesia [<a class="bk_pop" href="#prrt2-parox.REF.liu.2012.79">Liu et al 2012</a>], and episodic ataxia [<a class="bk_pop" href="#prrt2-parox.REF.gardiner.2012.2115">Gardiner et al 2012</a>, <a class="bk_pop" href="#prrt2-parox.REF.labate.2012.e196">Labate et al 2012</a>, <a class="bk_pop" href="#prrt2-parox.REF.delcourt.2015.782">Delcourt et al 2015</a>]. Thus, it is likely that the understanding of the spectrum of associated phenotypes is still evolving [<a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>].</p><div id="prrt2-parox.Paroxysmal_Kinesigenic_Dyski_2"><h4>Paroxysmal Kinesigenic Dyskinesia (PKD)</h4><p>To date, the primary paroxysmal movement disorder of <i>PRRT2-</i>PxMD is PKD (see Suggestive Findings, <a href="#prrt2-parox.Paroxysmal_Kinesigenic_Dyski">PKD</a>). Paroxysmal attacks are often characterized by dystonia, followed by choreoathetosis, and rarely ballism. Attacks often occur bilaterally. The arms are the most commonly involved, followed in decreasing order by involvement of the legs, trunk, face, and neck.</p><p>Onset of <i>PRRT2</i>-PKD is in childhood or adolescence (mean age: 10.3&#x000b1;4.9 [SD] years; range: 1-20 years) [<a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>].</p><p>The most common triggers are sudden voluntary movements, stress, being startled, intent to perform a voluntary movement, and sleep deprivation. While caffeine and alcohol are precipitating factors in a few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and attacks at rest are reported in approximately 2% of affected individuals, both of these triggers are more typical of <a href="/books/n/gene/pnknd/">paroxysmal nonkinesigenic dyskinesia</a> (PNKD) than PKD.</p><p>A nonspecific aura precedes PKD attacks in about 10% of individuals. Reported aura symptoms include a crawling sensation in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> limb, paresthesias, or nonspecific epigastric discomfort.</p><p>Attacks are usually brief &#x02013; in the range of a few seconds &#x02013; but in some individuals last five minutes or more.</p><p>The frequency of attacks is highly variable, ranging from 100 per day to one per week [<a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>].</p><p>Attacks tend to become less frequent with age and often respond well to anticonvulsants such as carbamazepine.</p></div><div id="prrt2-parox.Benign_Familial_Infantile_Ep_1"><h4>Benign Familial Infantile Epilepsy (BFIE)</h4><p>The seizures are complex partial seizures or localization-related epilepsy (see Suggestive Findings, <a href="#prrt2-parox.Benign_Familial_Infantile_Ep">BFIE</a>). Ictal patterns have been described as focal; onset has been reported in temporal, central, parietal, and occipital areas, with or without secondary generalization [<a class="bk_pop" href="#prrt2-parox.REF.caraballo.2002.696">Caraballo et al 2002</a>].</p><p>Seizures may occur in clusters with multiple complex partial seizures per day. Less common are motor arrest, decreased responsiveness, and automatisms [<a class="bk_pop" href="#prrt2-parox.REF.watanabe.1987.208">Watanabe et al 1987</a>]. Seizures rarely progress into status epilepticus. While respiratory depression can occur either during seizures or from medications including benzodiazepines, sudden unexpected death in epilepsy and long-term sequelae have not been reported.</p><p>In the vast majority of individuals the interictal EEG is unremarkable. In rare instances interictal focal epileptiform discharges may be seen, including bilateral centrotemporal spikes [<a class="bk_pop" href="#prrt2-parox.REF.seo.2016.s157">Seo &#x00026; You 2016</a>], bilateral parietotemporal spikes [<a class="bk_pop" href="#prrt2-parox.REF.torisu.2014.342">Torisu et al 2014</a>], and unilateral frontocentral spikes [<a class="bk_pop" href="#prrt2-parox.REF.el_achkar.2017">El Achkar et al 2017</a>].</p><p>Epilepsy-related brain MRI abnormalities are not reported.</p></div><div id="prrt2-parox.Paroxysmal_Kinesigenic_Dyski_3"><h4>Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions (PKD/IC)</h4><p>A seizure disorder in the form of BFIE is present in about 30% of <i>PRRT2</i>-PKD, leading to the diagnosis of PKD/IC. It is currently unknown how frequently BFIE evolves into PKD/IC.</p></div><div id="prrt2-parox.Hemiplegic_Migraine_HM_1"><h4>Hemiplegic Migraine (HM)</h4><p>HM falls within the classification of migraines with aura, characterized by an aura that localizes to the cerebral cortex. These auras comprise the following (in order of frequency):</p><ul><li class="half_rhythm"><div>Visual symptoms or disturbance (e.g., scotoma, photopsia, or diplopia)</div></li><li class="half_rhythm"><div>Sensory loss (e.g., numbness or paresthesias)</div></li><li class="half_rhythm"><div>Dysphasia</div></li></ul><p>HM additionally presents with motor symptoms in the form of some degree of hemiparesis.</p><p>Attack frequency often declines over time. Many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals even report a complete remission during adulthood. Improvement during pregnancy has also been observed [<a class="bk_pop" href="#prrt2-parox.REF.bruno.2004.2280">Bruno et al 2004</a>].</p></div></div><div id="prrt2-parox.GenotypePhenotype_Correlatio"><h3>Genotype-Phenotype Correlations</h3><p>No clear evidence for <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> exists for PKD, BFIE, PKD/IC, and HM, the four core <i>PRRT2-</i>PxMD phenotypes [<a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>]. Considerable variation in phenotype is seen both within and between families with the same pathogenic <i>PRRT2</i> variant.</p><p>Individuals with a 16p11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> who have <i>PRRT2-</i>PKD tend to have additional clinical features including developmental delay, intellectual disability, and/or autism spectrum disorder [<a class="bk_pop" href="#prrt2-parox.REF.dale.2012.618">Dale et al 2012</a>, <a class="bk_pop" href="#prrt2-parox.REF.silveiramoriyama.2013.327">Silveira-Moriyama et al 2013</a>, <a class="bk_pop" href="#prrt2-parox.REF.weber.2013.251">Weber et al 2013</a>, <a class="bk_pop" href="#prrt2-parox.REF.termsarasab.2014.274">Termsarasab et al 2014</a>].</p><p>Individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>PRRT2</i> pathogenic variants tend to have a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> that often includes intellectual disability, episodic ataxia, and different seizure types [<a class="bk_pop" href="#prrt2-parox.REF.labate.2012.e196">Labate et al 2012</a>, <a class="bk_pop" href="#prrt2-parox.REF.delcourt.2015.782">Delcourt et al 2015</a>].</p></div><div id="prrt2-parox.Penetrance"><h3>Penetrance</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> for <i>PRRT2</i>-PKD has been estimated to be 60%-90% [<a class="bk_pop" href="#prrt2-parox.REF.van_vliet.2012.777">van Vliet et al 2012</a>]; thus, individuals with a known <i>PRRT2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may be clinically unaffected.</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> for <i>PRRT2</i>-BFIE and <i>PRRT2-</i>HM is unknown.</p></div><div id="prrt2-parox.Nomenclature"><h3>Nomenclature</h3><p>Paroxysmal kinesigenic dyskinesia (PKD) was formerly known as paroxysmal kinesigenic choreoathetosis (PKC).</p><p>Benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile epilepsy (BFIE) is also known as benign familial infantile seizures (BFIS).</p><p>Paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC) was formerly known as infantile convulsions and choreoathetosis (ICCA).</p><p>Current recommendations are use of the designation <i>PRRT2</i>-PxMD for paroxysmal movement disorders associated with <i>PRRT2</i> [<a class="bk_pop" href="#prrt2-parox.REF.marras.2016.436">Marras et al 2016</a>].</p></div><div id="prrt2-parox.Prevalence"><h3>Prevalence</h3><p>The <i>PRRT2</i>-associated paroxysmal movement disorders (<i>PRRT2</i>-PxMD) are rare.</p><p>Prevalence for PKD, the most common of the paroxysmal movement disorders (including both <i>PRRT2</i>-PxMD and PKD of unknown or secondary cause), has been estimated at 1:150,000 individuals [<a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>].</p><p>To date approximately 600 individuals with <i>PRRT2</i>-BFIE, 560 with <i>PRRT2</i>-PKD, and 210 with <i>PRRT2</i>-PKD/IC have been reported [<a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>].</p><p>The majority of these individuals are of Asian ethnicity from China and Japan, followed by individuals from North America and Europe.</p><p><i>PRRT2</i>-PKD appears to be more common in males with about 1.5-fold more males reported than females.</p></div></div><div id="prrt2-parox.Genetically_Related_Allelic"><h2 id="_prrt2-parox_Genetically_Related_Allelic_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>PRRT2</i>.</p></div><div id="prrt2-parox.Differential_Diagnosis"><h2 id="_prrt2-parox_Differential_Diagnosis_">Differential Diagnosis</h2><p><i>PRRT2</i> pathogenic variants are found in the majority of individuals with paroxysmal kinesigenic dyskinesia (PKD), benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile epilepsy (BFIE), and paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), confirming a common disease spectrum that had previously been suspected based on linkage analyses [<a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>].</p><p><a href="/books/n/gene/fhm/">Familial hemiplegic migraine</a>, defined as the presence of at least one <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a> with identical attacks, has been associated with pathogenic variants in <i>CACNA1A</i> (designated FHM1), <i>ATP1A2</i> (FHM2), and <i>SCN1A</i> (FHM3).</p><div id="prrt2-parox.T.genetic_disorders_to_consi" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Genetic Disorders to Consider in the Differential Diagnosis of <i>PRRT2</i>-Associated Paroxysmal Movement Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK475803/table/prrt2-parox.T.genetic_disorders_to_consi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prrt2-parox.T.genetic_disorders_to_consi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of the Disorder</th></tr><tr><th headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4" id="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/<i>PRRT2</i>-PXMD</th><th headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4" id="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from <i>PRRT2</i>-PXMD</th></tr></thead><tbody><tr><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pnknd/">Paroxysmal nonkinesigenic dyskinesia (PNKD)</a></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PNKD</i></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paroxysmal dyskinesias</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No kinesigenic trigger. Attacks:
<ul><li class="half_rhythm"><div>Occur at rest, often precipitated by caffeine or alcohol;</div></li><li class="half_rhythm"><div>Last longer (usually mins to hrs) &#x00026; tend to occur less frequently (a few per day).</div></li></ul>
</td></tr><tr><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/glut1/">Paroxysmal exertion-induced dyskinesia (PED)</a></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC2A1</i></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD (<i>SLC2A1</i>-PxMD)</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paroxysmal dyskinesias</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Attacks:
<ul><li class="half_rhythm"><div>Triggered by prolonged exertion or exercise for usually 5-15 min</div></li><li class="half_rhythm"><div>Duration often in the range of mins (often up to 30 min)</div></li></ul>
</td></tr><tr><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/glut1/">GLUT1 deficiency syndrome</a></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC2A1</i></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paroxysmal dyskinesias</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Includes a spectrum of manifestations:
<ul><li class="half_rhythm"><div>PED</div></li><li class="half_rhythm"><div>Classic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> w/infantile-onset epileptic encephalopathy</div></li><li class="half_rhythm"><div>Atypical phenotypes w/out epilepsy incl mixed movement disorders &#x00026; ID or adult-onset w/minimal symptoms</div></li></ul>
</td></tr><tr><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Episodic ataxia (see <a href="/books/n/gene/ea1/">Episodic Ataxia Type 1</a> and <a href="/books/n/gene/ea2/">Episodic Ataxia Type 2</a>)</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNA1</i><br /><i>CACNA1A</i><br /><i>SLC1A3</i></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paroxysmal ataxia</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Brief intermittent episodes of ataxia of variable duration</td></tr><tr><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/adcy5-dysk/"><i>ADCY5</i>-related dyskinesia</a></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADCY5</i></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paroxysmal dyskinesias</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Attacks:
<ul><li class="half_rhythm"><div>Involve the limbs, neck, and/or face</div></li><li class="half_rhythm"><div>Often exacerbated by anxiety</div></li><li class="half_rhythm"><div>Often also facial "twitches"</div></li></ul>
Hypotonia &#x00026; delayed motor milestones may be present.</td></tr><tr><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fhm/">Familial hemiplegic migraine</a></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CACNA1A</i><br /><i>ATP1A2</i><br /><i>SCN1A</i></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paroxysmal hemiplegia</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Positive family history</td></tr><tr><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Alternating hemiplegia of childhood (See <a href="/books/n/gene/rapid-odp/"><i>ATP1A3</i>-Related Neurologic Disorders</a>)</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP1A2</i><br /><i>ATP1A3</i></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paroxysmal hemiplegia and dystonia</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Attacks last longer.</div></li><li class="half_rhythm"><div>Recurrent hemiplegia</div></li><li class="half_rhythm"><div>Onset age &#x0003c;18 mos</div></li><li class="half_rhythm"><div>Variable other transient neurologic findings</div></li><li class="half_rhythm"><div>Progressive cognitive deficits</div></li></ul>
</td></tr><tr><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/wilson/">Wilson disease</a></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP7B</i></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dyskinesias</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hepatic, neurologic, and/or psychiatric manifestations</div></li><li class="half_rhythm"><div>Persistent movement disorder, often incl tremor or rigid dystonia</div></li></ul>
</td></tr><tr><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Simple febrile seizures, complex febrile seizures, genetic epilepsy with febrile seizures plus (GEFS+) (see <a href="/books/n/gene/gefs/"><i>SCN1A</i>-Related Seizure Disorders</a>)</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN1A</i>, <i>SCN1B</i>, and others</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD or <a class="def" href="/books/n/gene/glossary/def-item/multifactorial/">multifactorial</a></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Seizures in the setting of fever</div></li><li class="half_rhythm"><div>Often later onset of seizures</div></li></ul>
</td></tr><tr><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Benign (<a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a>) neonatal infantile epilepsy (see <a href="/books/n/gene/bfns/"><i>KCNQ2</i>-Related Disorders</a> and <a href="/books/n/gene/kcnq3-dis/"><i>KCNQ3</i>-Related Disorders</a>)</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNQ2</i>, <i>KCNQ3</i></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Earlier age of onset</td></tr><tr><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Benign (<a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a>) neonatal infantile epilepsy (OMIM: <a href="https://omim.org/entry/607745" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">607745</a>)</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN2A</i></td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures</td><td headers="hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_1_4 hd_h_prrt2-parox.T.genetic_disorders_to_consi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Earlier age of onset</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a></p></div></dd><dt></dt><dd><div><p class="no_margin">PED = paroxysmal exertion-induced dyskinesia</p></div></dd><dt></dt><dd><div><p class="no_margin">ID = intellectual disability</p></div></dd></dl></div></div></div></div><div id="prrt2-parox.Management"><h2 id="_prrt2-parox_Management_">Management</h2><div id="prrt2-parox.Evaluations_Following_Initia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with a <i>PRRT2</i>-associated paroxysmal movement disorder <i>(PRRT2-</i>PxMD), the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Consultation with a neurologist who is a specialist in epilepsy and/or movement disorders</div></li><li class="half_rhythm"><div>Patients with PKD. Consider MRI to evaluate for other causes (e.g., hemorrhage, stroke, focal cortical dysplasia).</div></li><li class="half_rhythm"><div>Patients with atypical or ambiguous paroxysmal movements. Consider EEG to evaluate for possible seizures.</div></li><li class="half_rhythm"><div>Patients with seizures. Consider:</div><ul><li class="half_rhythm"><div>Basic laboratory tests to evaluate for other causes of seizures;</div></li><li class="half_rhythm"><div>EEG to confirm normal background for age (capturing seizures on EEG may not be necessary if events are clinically consistent with seizures).</div></li></ul></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="prrt2-parox.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="prrt2-parox.PKD"><h4>PKD</h4><p>Attack frequency is reduced or prevented by treatment with low doses of antiepileptic drugs (AEDs).</p><ul><li class="half_rhythm"><div>Carbamazepine is often effective. Note that doses lower than those used to treat epilepsy are usually sufficient.</div></li><li class="half_rhythm"><div>Other AEDs including phenytoin, valproate, oxcarbazepine, lamotrigine, levetiracetam, or topiramate may also be effective.</div></li></ul><p>Avoiding stress, sleep deprivation, anxiety, and other triggers that increase the likelihood for PKD episodes can help prevent attacks and can lower attack frequency.</p><p>No other pharmacotherapies or non-pharmacologic treatments have been investigated systematically.</p></div><div id="prrt2-parox.BFIE"><h4>BFIE</h4><p>Seizure frequency is decreased by therapeutic doses of AEDs. Although response to carbamazepine or oxcarbazepine has not been well studied, these tend to be the preferred AEDs given the known favorable response in PKD and anecdotal response in HM.</p><p>During seizures lasting longer than five minutes or seizure clusters, benzodiazepines including lorazepam, diazepam, or midazolam can be used. Anecdotally, however, the response to benzodiazepines in <i>PRRT2</i>-associated seizures is less robust.</p><p>In patients with BFIE, no specific interventions are known to decrease the risk of later developing PKD.</p></div></div><div id="prrt2-parox.Prevention_of_Secondary_Comp"><h3>Prevention of Secondary Complications</h3><p><b>PKD.</b> Falls and interference with activities such as driving are potential secondary complications. Counseling is needed to prevent these potential secondary complications.</p></div><div id="prrt2-parox.Surveillance"><h3>Surveillance</h3><p><b>PKD.</b> Individuals with PKD or PKD/IC can be monitored clinically every one to two years, particularly with respect to evaluating medication needs and dosing. More frequent visits may be necessary in individuals who have not achieved sufficient control of attacks or children who need weight-based adjustment of medication doses.</p><p><b>BFIE.</b> Patients are monitored clinically for seizures and AEDs are adjusted accordingly. Depending on the agent used, medication serum levels &#x02013; as well as liver enzymes, complete blood count, electrolytes, and vitamin D levels &#x02013; should be monitored periodically. Repeat EEGs are only recommended when there is concern for subclinical seizures.</p><p>While <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>PRRT2</i> pathogenic variants are not known to be associated with an increased risk for developmental abnormalities, any seizure disorder carries the theoretic increased risk of developmental delay; thus, early developmental surveillance is recommended.</p></div><div id="prrt2-parox.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p><b>PKD.</b> Stress, sleep deprivation, and anxiety are consistently reported as factors that increase the likelihood for PKD episodes; avoiding these or other triggers can help prevent attacks and can lower attack frequency.</p><p><b>BFIE.</b> Treat fevers promptly.</p></div><div id="prrt2-parox.Evaluation_of_Relatives_at_R"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#prrt2-parox.Related_Genetic_Counseling_I">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="prrt2-parox.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Prenatal exposure to AEDs may increase the risk for adverse fetal outcome (depending on the drug used, the dose, and the stage of pregnancy at which medication is taken). Discussion of the risks and benefits of using a given AED during pregnancy should ideally take place prior to conception. Because of the fetal risk related to anticonvulsant therapy, women with mild manifestations of PKD may consider discontinuing anticonvulsant therapy prior to or during pregnancy. Alternatively, transitioning to a lower-risk AED prior to pregnancy may be considered [<a class="bk_pop" href="#prrt2-parox.REF.sarma.2016.467">Sarma et al 2016</a>].</p><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for more information on medication use during pregnancy.</p></div><div id="prrt2-parox.Therapies_Under_Investigatio"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="prrt2-parox.Genetic_Counseling"><h2 id="_prrt2-parox_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="prrt2-parox.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>PRRT2</i>-associated paroxysmal movement disorders (<i>PRRT2</i>-PxMD) caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>PRRT2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or, in rare cases, 16p11.2 <a class="def" href="/books/n/gene/glossary/def-item/recurrent-deletion/">recurrent deletion</a> (that includes <i>PRRT2</i>), are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. (See <a href="/books/n/gene/del16p11_2/">16p11.2 Recurrent Deletion</a> for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> information specific to the 16p11.2 recurrent deletion.)</p><p>In rare cases (typically associated with a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>), <i>PRRT2</i>-PxMD may be associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>PRRT2</i> pathogenic variants and inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner [<a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>].</p></div><div id="prrt2-parox.Risk_to_Family_Members__Auto"><h3>Risk to Family Members &#x02013; Autosomal Dominant Inheritance, <i>PRRT2</i> Pathogenic Variant</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>About 90% of individuals diagnosed with a <i>PRRT2</i>-PxMD have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent or other family member [<a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>]. Reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> lead to clinical variability within families.</div></li><li class="half_rhythm"><div>About 10% of individuals diagnosed with a <i>PRRT2</i>-PxMD have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <i>PRRT2 de novo</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <i>PRRT2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Though theoretically possible, to date no instances of germline mosaicism have been reported.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with a <i>PRRT2</i>-PxMD may appear to be negative because of failure to recognize the disorder in family members particularly given that symptoms tend to become less frequent in adulthood. Therefore, an apparently negative family history cannot be confirmed unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or is known to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <i>PRRT2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs is 50%. Reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> are commonly observed, leading to phenotypic variability within families.</div></li><li class="half_rhythm"><div>If the <i>PRRT2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the empiric <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is approximately 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#prrt2-parox.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>The sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still at increased risk for <i>PRRT2</i>-PxMD because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent and the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>PRRT2</i>-PxMD has a 50% chance of inheriting the <i>PRRT2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> are commonly observed, leading to phenotypic variability within families.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>PRRT2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="prrt2-parox.Risk_to_Family_Members__Auto_1"><h3>Risk to Family Members &#x02013; Autosomal Recessive Inheritance, Biallelic <i>PRRT2</i> Pathogenic Variants</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes and therefore carry a single copy of a <i>PRRT2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant has not yet been documented to cause <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> <i>PRRT2</i>-PXMD).</div></li><li class="half_rhythm"><div>Heterozygotes may be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with a <i>PRRT2</i>-PxMD or may be asymptomatic given reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and clinical variability.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a 25% chance of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes may be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with a <i>PRRT2</i>-PxMD or may be asymptomatic given reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and clinical variability.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>.</p><p><b>Carrier (<a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a>) detection.</b> Testing for at-risk relatives requires prior identification of the <i>PRRT2</i> pathogenic variants in the family.</p></div><div id="prrt2-parox.Related_Genetic_Counseling_I"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning.</b> It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</p><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="prrt2-parox.Prenatal_Testing_and_Preimpl"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>PRRT2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="prrt2-parox.Resources"><h2 id="_prrt2-parox_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Bachmann-Strauss Dystonia &#x00026; Parkinson Foundation</b></div><div><a href="http://www.dystonia-parkinson.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dystonia-parkinson.org</a></div></li><li class="half_rhythm"><div><b>Child Neurology Foundation (CNF)</b></div><div>2000 West 98th Street</div><div>Bloomington MN 55431</div><div><b>Phone:</b> 877-263-5430 (toll-free); 952-641-6100</div><div><b>Email:</b> jstone@childneurologyfoundation.org</div><div><a href="http://www.childneurologyfoundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.childneurologyfoundation.org</a></div></li><li class="half_rhythm"><div><b>Dystonia Europe</b></div><div>Square de Meeus 37</div><div>4th Floor</div><div> Brussels Hoofdstedelijk Gewest 1000</div><div>Belgium</div><div><b>Phone:</b> 46 739 98 49 61</div><div><b>Email:</b> sec@dystonia-europe.org</div><div><a href="https://dystonia-europe.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dystonia-europe.org</a></div></li><li class="half_rhythm"><div><b>Dystonia Medical Research Foundation</b></div><div>One East Wacker Drive</div><div>Suite 1730</div><div>Chicago IL 60601-1905</div><div><b>Phone:</b> 800-377-3978 (toll-free); 312-755-0198</div><div><b>Fax:</b> 312-803-0138</div><div><b>Email:</b> dystonia@dystonia-foundation.org</div><div><a href="http://www.dystonia-foundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dystonia-foundation.org</a></div></li></ul></div><div id="prrt2-parox.Molecular_Genetics"><h2 id="_prrt2-parox_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="prrt2-parox.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>PRRT2-Associated Paroxysmal Movement Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK475803/table/prrt2-parox.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prrt2-parox.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_prrt2-parox.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_prrt2-parox.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_prrt2-parox.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_prrt2-parox.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_prrt2-parox.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_prrt2-parox.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_prrt2-parox.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/112476" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PRRT2</i></a></td><td headers="hd_b_prrt2-parox.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=112476" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">16p11<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_prrt2-parox.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q7Z6L0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Proline-rich transmembrane protein 2</a></td><td headers="hd_b_prrt2-parox.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/PRRT2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PRRT2 @ LOVD</a><br /><a href="http://www.mdsgene.org/d/2/g/5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Movement Disorder Society Genetic mutation database (PRRT2)</a></td><td headers="hd_b_prrt2-parox.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PRRT2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PRRT2</a></td><td headers="hd_b_prrt2-parox.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PRRT2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PRRT2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="prrt2-parox.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="prrt2-parox.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for PRRT2-Associated Paroxysmal Movement Disorders (<a href="/omim/128200,602066,605751,611913,614386" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK475803/table/prrt2-parox.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prrt2-parox.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/128200" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">128200</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPISODIC KINESIGENIC DYSKINESIA 1; EKD1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602066" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602066</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS; ICCA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605751" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605751</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611913" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611913</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614386" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614386</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PROLINE-RICH TRANSMEMBRANE PROTEIN 2; PRRT2</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>PRRT2</i> consists of four exons encoding a 340-amino acid protein. Alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> at the 3' terminus leads to six splice variants. Three different <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> exist; nearly all known pathogenic variants in <i>PRRT2</i> locate to a conserved region present in all isoforms. See <a href="/books/NBK475803/#prrt2-parox.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> The majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (~80%) have the same frameshift <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, c.649dupC [<a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>].</p><p>A summary of reported pathogenic variants [<a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>] is available through the Movement Disorder Society Genetic Mutation Database (see <a href="/books/NBK475803/#prrt2-parox.molgen.TA">Table A</a>).</p><div id="prrt2-parox.T.prrt2_pathogenic_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>PRRT2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK475803/table/prrt2-parox.T.prrt2_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prrt2-parox.T.prrt2_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_prrt2-parox.T.prrt2_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_prrt2-parox.T.prrt2_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_prrt2-parox.T.prrt2_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_prrt2-parox.T.prrt2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.649dupC</td><td headers="hd_h_prrt2-parox.T.prrt2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg217ProfsTer8</td><td headers="hd_h_prrt2-parox.T.prrt2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_145239.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_145239<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_660282.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_660282<wbr style="display:inline-block"></wbr>​.2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> PRRT2 is predicted to contain a proline-rich <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> within its N-terminal extracellular region and two putative transmembrane domains at the C-terminal end. PRRT2 is thus predicted to be a membrane-bound protein.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most reported pathogenic variants in <i>PRRT2</i>, including the common c.649dupC variant, lead to unstable messenger RNA or a truncated protein product that undergoes rapid degradation [<a class="bk_pop" href="#prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari et al 2015</a>]. The mechanism is thus consistent with a loss of function of PRRT2.</p><p>Available evidence in cell culture models suggests that PRRT2 is involved in regulating synaptic vesicle release [<a class="bk_pop" href="#prrt2-parox.REF.valente.2016.117">Valente et al 2016</a>]. Loss of <i>PRRT2</i> in cultured cells and transgenic mice leads to aberrant synaptic transmission [<a class="bk_pop" href="#prrt2-parox.REF.valente.2016.117">Valente et al 2016</a>, <a class="bk_pop" href="#prrt2-parox.REF.michetti.2017.66">Michetti et al 2017</a>, <a class="bk_pop" href="#prrt2-parox.REF.tan.2018.90">Tan et al 2018</a>].</p></div><div id="prrt2-parox.References"><h2 id="_prrt2-parox_References_">References</h2><div id="prrt2-parox.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.becker.2013.1234">Becker F, Schubert J, Striano P, Anttonen AK, Liukkonen E, Gaily E, Gerloff C, M&#x000fc;ller S, Heu&#x000df;inger N, Kellinghaus C, Robbiano A, Polvi A, Zittel S, von Oertzen TJ, Rostasy K, Sch&#x000f6;ls L, Warner T, M&#x000fc;nchau A, Lehesjoki AE, Zara F, Lerche H, Weber YG. PRRT2-related disorders: further PKD and ICCA cases and review of the literature. <span><span class="ref-journal">J Neurol. </span>2013;<span class="ref-vol">260</span>:1234–44.</span> [<a href="/pubmed/23299620" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23299620</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.bruno.2004.2280">Bruno MK, Hallett M, Gwinn-Hardy K, Sorensen B, Considine E, Tucker S, Lynch DR, Mathews KD, Swoboda KJ, Harris J, Soong BW, Ashizawa T, Jankovic J, Renner D, Fu YH, Ptacek LJ. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">63</span>:2280–7.</span> [<a href="/pubmed/15623687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15623687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.caraballo.2002.696">Caraballo RH, Cers&#x000f3;simo RO, Amartino H, Szepetowski P, Fejerman N. Benign familial infantile seizures: further delineation of the syndrome. <span><span class="ref-journal">J Child Neurol. </span>2002;<span class="ref-vol">17</span>:696–9.</span> [<a href="/pubmed/12503648" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12503648</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.chen.2011.1252">Chen WJ, Lin Y, Xiong ZQ, Wei W, Ni W, Tan GH, Guo SL, He J, Chen YF, Zhang QJ, Li HF, Lin Y, Murong SX, Xu J, Wang N, Wu ZY. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:1252–5.</span> [<a href="/pubmed/22101681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22101681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.dale.2012.618">Dale RC, Grattan-Smith P, Nicholson M, Peters GB. Microdeletions detected using chromosome microarray in children with suspected genetic movement disorders: a single-centre study. <span><span class="ref-journal">Dev Med Child Neurol. </span>2012;<span class="ref-vol">54</span>:618–23.</span> [<a href="/pubmed/22515636" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22515636</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.delcourt.2015.782">Delcourt M, Riant F, Mancini J, Milh M, Navarro V, Roze E, Humbertclaude V, Korff C, Des Portes V, Szepetowski P, Doummar D, Echenne B, Quintin S, Leboucq N, Singh Amrathlal R, Rochette J, Roubertie A. Severe phenotypic spectrum of biallelic mutations in PRRT2 gene. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2015;<span class="ref-vol">86</span>:782–5.</span> [<a href="/pubmed/25595153" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25595153</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.ebrahimifakhari.2015.3476">Ebrahimi-Fakhari D, Saffari A, Westenberger A, Klein C. The evolving spectrum of PRRT2-associated paroxysmal diseases. <span><span class="ref-journal">Brain. </span>2015;<span class="ref-vol">138</span>:3476–95.</span> [<a href="/pubmed/26598493" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26598493</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.el_achkar.2017">El Achkar CM, Rosen Sheidley B, O'Rourke D, Takeoka M, Poduri A. Compound heterozygosity with PRRT2: pushing the phenotypic envelope in genetic epilepsies. Epilepsy &#x00026; Behavior Case Reports. Available <a href="https://www.sciencedirect.com/science/article/pii/S2213323216300755" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2017. Accessed 1-9-18. [<a href="/pmc/articles/PMC6525261/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6525261</span></a>] [<a href="/pubmed/31193310" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31193310</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.gardiner.2012.2115">Gardiner AR, Bhatia KP, Stamelou M, Dale RC, Kurian MA, Schneider SA, Wali GM, Counihan T, Schapira AH, Spacey SD, Valente EM, Silveira-Moriyama L, Teive HA, Raskin S, Sander JW, Lees A, Warner T, Kullmann DM, Wood NW, Hanna M, Houlden H. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">79</span>:2115–21.</span> [<a href="/pmc/articles/PMC3511930/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3511930</span></a>] [<a href="/pubmed/23077024" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23077024</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF10">Headache Classification Committee. 2013. The International Headache Society (IHS) International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33: 629-808. [<a href="/pubmed/23771276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23771276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.labate.2012.e196">Labate A, Tarantino P, Viri M, Mumoli L, Gagliardi M, Romeo A, Zara F, Annesi G, Gambardella A. Homozygous c.649dupC mutation in PRRT2 worsens the BFIS/PKD phenotype with mental retardation, episodic ataxia, and absences. <span><span class="ref-journal">Epilepsia. </span>2012;<span class="ref-vol">53</span>:e196–9.</span> [<a href="/pubmed/23126439" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23126439</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.liu.2012.79">Liu Q, Qi Z, Wan XH, Li JY, Shi L, Lu Q, Zhou XQ, Qiao L, Wu LW, Liu XQ, Yang W, Liu Y, Cui LY, Zhang X. Mutations in PRRT2 result in paroxysmal dyskinesias with marked variability in clinical expression. <span><span class="ref-journal">J Med Genet. </span>2012;<span class="ref-vol">49</span>:79–82.</span> [<a href="/pubmed/22209761" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22209761</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.liu.2013.234">Liu XR, Wu M, He N, Meng H, Wen L, Wang JL, Zhang MP, Li WB, Mao X, Qin JM, Li BM, Tang B, Deng YH, Shi YW, Su T, Yi YH, Tang BS, Liao WP. Novel PRRT2 mutations in paroxysmal dyskinesia patients with variant inheritance and phenotypes. <span><span class="ref-journal">Genes Brain Behav. </span>2013;<span class="ref-vol">12</span>:234–40.</span> [<a href="/pubmed/23190448" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23190448</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.marras.2016.436">Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C. Nomenclature of genetic movement disorders: recommendations of the international Parkinson and movement disorder society task force. <span><span class="ref-journal">Mov Disord. </span>2016;<span class="ref-vol">31</span>:436–57.</span> [<a href="/pubmed/27079681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27079681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.michetti.2017.66">Michetti C, Castroflorio E, Marchionni I, Forte N, Sterlini B, Binda F, Fruscione F, Baldelli P, Valtorta F, Zara F, Corradi A, Benfenati F. The PRRT2 knockout mouse recapitulates the neurological diseases associated with PRRT2 mutations. <span><span class="ref-journal">Neurobiol Dis. </span>2017;<span class="ref-vol">99</span>:66–83.</span> [<a href="/pmc/articles/PMC5321265/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5321265</span></a>] [<a href="/pubmed/28007585" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28007585</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR. UK10K Consortium, Hurles ME. Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.sarma.2016.467">Sarma AK, Khandker N, Kurczewski L, Brophy GM. Medical management of epileptic seizures: challenges and solutions. <span><span class="ref-journal">Neuropsychiatr Dis Treat. </span>2016;<span class="ref-vol">12</span>:467–85.</span> [<a href="/pmc/articles/PMC4771397/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4771397</span></a>] [<a href="/pubmed/26966367" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26966367</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.scheffer.2012.2104">Scheffer IE, Grinton BE, Heron SE, Kivity S, Afawi Z, Iona X, Goldberg-Stern H, Kinali M, Andrews I, Guerrini R, Marini C, Sadleir LG, Berkovic SF, Dibbens LM. PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">79</span>:2104–8.</span> [<a href="/pmc/articles/PMC3511925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3511925</span></a>] [<a href="/pubmed/23077018" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23077018</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.seo.2016.s157">Seo SY, You SJ. Paroxysmal kinesigenic dyskinesia in a patient with a PRRT2 mutation and centrotemporal spike discharges on electroencephalogram: case report of a 10-year-old girl. <span><span class="ref-journal">Korean J Pediatr. </span>2016;<span class="ref-vol">59</span>:S157–S160.</span> [<a href="/pmc/articles/PMC5177702/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5177702</span></a>] [<a href="/pubmed/28018471" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28018471</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.silveiramoriyama.2013.327">Silveira-Moriyama L, Gardiner AR, Meyer E, King MD, Smith M, Rakshi K, Parker A, Mallick AA, Brown R, Vassallo G, Jardine PE, Guerreiro MM, Lees AJ, Houlden H, Kurian MA. Clinical features of childhood-onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations. <span><span class="ref-journal">Dev Med Child Neurol. </span>2013;<span class="ref-vol">55</span>:327–34.</span> [<a href="/pubmed/23363396" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23363396</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.specchio.2006.s156">Specchio N, Vigevano F. The spectrum of benign infantile seizures. <span><span class="ref-journal">Epilepsy Res. </span>2006;<span class="ref-vol">70</span> Suppl 1:S156–67.</span> [<a href="/pubmed/16837167" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16837167</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.tan.2018.90">Tan GH, Liu YY, Wang L, Li K, Zhang ZQ, Li HF, Yang ZF, Li Y, Li D, Wu MY, Yu CL, Long JJ, Chen RC, Li LX, Yin LP, Liu JW, Cheng XW, Shen Q, Shu YS, Sakimura K, Liao LJ, Wu ZY, Xiong ZQ. PRRT2 deficiency induces paroxysmal kinesigenic dyskinesia by regulating synaptic transmission in cerebellum. <span><span class="ref-journal">Cell Res. </span>2018;<span class="ref-vol">28</span>:90–110.</span> [<a href="/pmc/articles/PMC5752836/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5752836</span></a>] [<a href="/pubmed/29056747" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29056747</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.termsarasab.2014.274">Termsarasab P, Yang AC, Reiner J, Mei H, Scott SA, Frucht SJ. Paroxysmal kinesigenic dyskinesia caused by 16p11.2 microdeletion. <span><span class="ref-journal">Tremor Other Hyperkinet Mov (N Y). </span>2014;<span class="ref-vol">4</span>:274.</span> [<a href="/pmc/articles/PMC4303604/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4303604</span></a>] [<a href="/pubmed/25667815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25667815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.torisu.2014.342">Torisu H, Watanabe K, Shimojima K, Sugawara M, Sanefuji M, Ishizaki Y, Sakai Y, Yamashita H, Yamamoto T, Hara T. Girl with a PRRT2 mutation and infantile focal epilepsy with bilateral spikes. <span><span class="ref-journal">Brain Dev. </span>2014;<span class="ref-vol">36</span>:342–5.</span> [<a href="/pubmed/23768507" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23768507</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.valente.2016.117">Valente P, Castroflorio E, Rossi P, Fadda M, Sterlini B, Cervigni RI, Prestigio C, Gioved&#x000ec; S, Onofri F, Mura E, Guarnieri FC, Marte A, Orlando M, Zara F, Fassio A, Valtorta F, Baldelli P, Corradi A, Benfenati F. PRRT2 is a key component of the Ca(2+)-dependent neurotransmitter release machinery. <span><span class="ref-journal">Cell Rep. </span>2016;<span class="ref-vol">15</span>:117–31.</span> [<a href="/pmc/articles/PMC4826441/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4826441</span></a>] [<a href="/pubmed/27052163" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27052163</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.van_vliet.2012.777">van Vliet R, Breedveld G, de Rijk-van Andel J, Brilstra E, Verbeek N, Verschuuren-Bemelmans C, Boon M, Samijn J, Diderich K, van de Laar I, Oostra B, Bonifati V, Maat-Kievit A. PRRT2 phenotypes and penetrance of paroxysmal kinesigenic dyskinesia and infantile convulsions. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">79</span>:777–84.</span> [<a href="/pubmed/22875091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22875091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.vigevano.2005.172">Vigevano F. Benign familial infantile seizures. <span><span class="ref-journal">Brain Dev. </span>2005;<span class="ref-vol">27</span>:172–7.</span> [<a href="/pubmed/15737697" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15737697</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.wang.2011.3493">Wang JL, Cao L, Li XH, Hu ZM, Li JD, Zhang JG, Liang Y, San A, Li N, Chen SQ, Guo JF, Jiang H, Shen L, Zheng L, Mao X, Yan WQ, Zhou Y, Shi YT, Ai SX, Dai MZ, Zhang P, Xia K, Chen SD, Tang BS. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. <span><span class="ref-journal">Brain. </span>2011;<span class="ref-vol">134</span>:3493–3501.</span> [<a href="/pmc/articles/PMC3235563/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3235563</span></a>] [<a href="/pubmed/22120146" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22120146</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.wang.2013.664">Wang K, Zhao X, Du Y, He F, Peng G, Luo B. Phenotypic overlap among paroxysmal dyskinesia subtypes: lesson from a family with PRRT2 gene mutation. <span><span class="ref-journal">Brain Dev. </span>2013;<span class="ref-vol">35</span>:664–6.</span> [<a href="/pubmed/22902309" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22902309</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.watanabe.1987.208">Watanabe K, Yamamoto N, Negoro T, Takaesu E, Aso K, Furune S, Takahashi I. Benign complex partial epilepsies in infancy. <span><span class="ref-journal">Pediatr Neurol. </span>1987;<span class="ref-vol">3</span>:208–11.</span> [<a href="/pubmed/3508067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3508067</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.weber.2013.251">Weber A, K&#x000f6;hler A, Hahn A, Neubauer B, M&#x000fc;ller U. Benign infantile convulsions (IC) and subsequent paroxysmal kinesigenic dyskinesia (PKD) in a patient with 16p11.2 microdeletion syndrome. <span><span class="ref-journal">Neurogenetics. </span>2013;<span class="ref-vol">14</span>:251–3.</span> [<a href="/pubmed/24100940" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24100940</span></a>]</div></li></ul></div><div id="prrt2-parox.Suggested_Reading_Historical"><h3>Suggested Reading (Historical References)</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.demirkiran.1995.571">Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. <span><span class="ref-journal">Ann Neurol. </span>1995;<span class="ref-vol">38</span>:571–9.</span> [<a href="/pubmed/7574453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7574453</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.kato.2006.s174">Kato N, Sadamatsu M, Kikuchi T, Niikawa N, Fukuyama Y. Paroxysmal kinesigenic choreoathetosis: from first discovery in 1892 to genetic linkage with benign familial infantile convulsions. <span><span class="ref-journal">Epilepsy Res. </span>2006;<span class="ref-vol">70</span>:S174–84.</span> [<a href="/pubmed/16901678" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16901678</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.kertesz.1967.680">Kertesz A. Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied. <span><span class="ref-journal">Neurology. </span>1967;<span class="ref-vol">17</span>:680–90.</span> [<a href="/pubmed/6067487" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6067487</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prrt2-parox.REF.mount.1940.841">Mount LA, Reback S. Familial paroxysmal choreoathetosis. <span><span class="ref-journal">Arch Neurol Psychiatry. </span>1940;<span class="ref-vol">44</span>:841–7.</span></div></li></ul></div></div><div id="prrt2-parox.Chapter_Notes"><h2 id="_prrt2-parox_Chapter_Notes_">Chapter Notes</h2><div id="prrt2-parox.Author_Notes"><h3>Author Notes</h3><p>The Movement Disorder Society Genetic mutation database (MDSGene) provides a comprehensive, systematic overview of published data on movement disorder patients including patients with PKD. Please refer to <a href="http://www.mdsgene.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mdsgene.org</a>.</p><p>Recommendations on the Nomenclature of Genetic Movement Disorders are provided by the Task Force on the Nomenclature of Genetic Movement Disorders from the International Parkinson and Movement Disorders Society. Current recommendations are provided in <a class="bk_pop" href="#prrt2-parox.REF.marras.2016.436">Marras et al [2016]</a>.</p></div><div id="prrt2-parox.Acknowledgments"><h3>Acknowledgments</h3><p>We are grateful to the many patients and families who support research on <i>PRRT2</i>. For his work on <i>PRRT2</i>, DEF acknowledges support from the Young Investigator Award Program at Ruprecht-Karls-University Heidelberg Faculty of Medicine, the Daimler and Benz Foundation (Daimler und Benz Stiftung, Ladenburg, Germany), the Reinhard-Frank Foundation (Reinhard-Frank-Stiftung, Hamburg, Germany), and the Fred-Lovejoy Research and Education Fund (Boston, MA, USA).</p><p>CK acknowledges support from the Hermann and Lilly Schilling Foundation, the German Research Foundation, and the University of L&#x000fc;beck's intramural programs.</p></div><div id="prrt2-parox.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>11 January 2018 (bp) Review posted live</div></li><li class="half_rhythm"><div>16 August 2017 (def) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK475803</span><span class="label">PMID: <a href="/pubmed/29334453" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">29334453</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/prop1/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/prss1-hp/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK475803&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK475803/?report=reader">PubReader</a></li><li><a href="/books/NBK475803/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK475803" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK475803" style="display:none" title="Cite this Page"><div class="bk_tt">Ebrahimi-Fakhari D, Moufawad El Achkar C, Klein C. PRRT2-Associated Paroxysmal Movement Disorders. 2018 Jan 11. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK475803/pdf/Bookshelf_NBK475803.pdf">PDF version of this page</a> (476K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#prrt2-parox.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#prrt2-parox.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#prrt2-parox.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#prrt2-parox.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#prrt2-parox.Genetically_Related_Allelic" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#prrt2-parox.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#prrt2-parox.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#prrt2-parox.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#prrt2-parox.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#prrt2-parox.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#prrt2-parox.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#prrt2-parox.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=112476[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PRRT2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4489762" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4489762" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4489762" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4489762" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301633" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial Paroxysmal Kinesigenic Dyskinesia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial Paroxysmal Kinesigenic Dyskinesia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Spacey S, Adams P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301294" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24370076" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Phenotypes and PRRT2 mutations in Chinese families with benign familial infantile epilepsy and infantile convulsions with paroxysmal choreoathetosis.</a><span class="source">[BMC Neurol. 2013]</span><div class="brieflinkpop offscreen_noflow">Phenotypes and PRRT2 mutations in Chinese families with benign familial infantile epilepsy and infantile convulsions with paroxysmal choreoathetosis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yang X, Zhang Y, Xu X, Wang S, Yang Z, Wu Y, Liu X, Wu X. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMC Neurol. 2013 Dec 26; 13:209. Epub 2013 Dec 26.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301603" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang D, Pascual JM, De Vivo D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22875091" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">PRRT2 phenotypes and penetrance of paroxysmal kinesigenic dyskinesia and infantile convulsions.</a><span class="source">[Neurology. 2012]</span><div class="brieflinkpop offscreen_noflow">PRRT2 phenotypes and penetrance of paroxysmal kinesigenic dyskinesia and infantile convulsions.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">van Vliet R, Breedveld G, de Rijk-van Andel J, Brilstra E, Verbeek N, Verschuuren-Bemelmans C, Boon M, Samijn J, Diderich K, van de Laar I, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurology. 2012 Aug 21; 79(8):777-84. Epub 2012 Aug 8.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=29334453" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=29334453" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04153e39a66ee2ba02ab58">PRRT2-Associated Paroxysmal Movement Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">PRRT2-Associated Paroxysmal Movement Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:04:46-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE8976B4E040E5A10000000003690188&amp;ncbi_session=CE8976B4E04153E1_0873SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK475803%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK475803&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK475803/&amp;ncbi_pagename=PRRT2-Associated Paroxysmal Movement Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8976B4E04153E1_0873SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>